Life Sciences

Chris Corsico jumps from Boehringer to head development at GSK

September 19, 2018

When Boehringer Ingelheim announced last Monday that Chief Medical Officer Chris Corsico was on his way out, the company said only that he would be pursuing his career “outside of the company.” Now, Reuters reports, Corsico will fill a new role at GlaxoSmithKline: senior vice..

Virion Biotherapeutics fills out executive ranks with CEO, CSO

September 19, 2018

Virion Biotherapeutics announced Monday that Vanessa King and Isabel Najera have signed on as CEO and chief scientific officer, respectively. King has held a number of business development and operations roles, including at Novartis and deCode Genetics and has led Luc Therapeutics as its CEO…

Novo to lay off 400 staff in major R&D reorganization

September 18, 2018

Novo Nordisk is laying off 400 employees in China and Denmark as part of a reorganization of its R&D department. The reshuffle comes as the company seeks to build a pipeline of chronic disease drugs capable of mitigating the pressures faced by its core diabetes..

An industry abandoned

September 18, 2018

For many decades, the UK government has pursued twin objectives in its dealings with the pharmaceutical industry. On the one hand, it has sought to deliver value for money to the NHS. And, on the other, it has sought to support a flourishing life sciences..

Agfa Gevaert says Kanteron Systems takeover offer “not interesting”

September 17, 2018

Shares in digital imaging systems producer Agfa Gevaert climbed on Thursday after it said it had declined to engage in talks with privately-held Kanteron Systems regarding a potential takeover bid. The company said that it had received a non-binding letter of intent from Kanteron Systems..

Allergan defuses Botox threat with $195M Bonti buy

September 17, 2018

Allergan has agreed to pay $195 million to acquire Bonti, a startup founded by former Allergan executives focused on creating a new botulinum neurotoxin. The Big Pharma will pick up global rights to Bonti’s botulinum assets that are in development for cosmetic and therapeutic applications…

Roche steps up efficiency drive to take sting out of biosimilars

September 14, 2018

Roche, the world’s biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition from cut-price copies of three mega-brands from its famed U.S. Genentech biotech stable. Even though the Swiss company has some of the pharmaceutical industry’s..

Boehringer buys oncolytic virus startup ViraTherapeutics

September 14, 2018

Boehringer Ingelheim has bought oncolytic virus startup ViraTherapeutics. The takeover is focused on vesicular stomatitis virus (VSV) candidates Boehringer sees becoming key components of its efforts to gain ground in the immuno-oncology sector. Germany’s Boehringer secured the option to acquire ViraTherapeutics two years ago. That..

Sanofi swaps executives with Bayer in revamp that reshapes diabetes, spotlights China

September 14, 2018

You might have witnessed some asset swaps in the biopharma industry. Sanofi itself traded its animal health unit for Boehringer Ingelheim’s consumer health business. But what about an executive swap? Not so much. But now, Sanofi is exchanging top executives with Bayer as it pushes..

Half of European studies fail to report results: BMJ report

September 13, 2018

New research out by the BMJ shows that half of tracked clinical trials across Europe “have not reported trials,” but biopharmas are doing much better than its academic peers when it comes to disclosing data. These new data are out from the EUTrialsTracker tool, with..